BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Baldo A, Leunda A, Willemarck N, Pauwels K. Environmental Risk Assessment of Recombinant Viral Vector Vaccines against SARS-Cov-2. Vaccines (Basel) 2021;9:453. [PMID: 34063733 DOI: 10.3390/vaccines9050453] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Stokes AH, Planty C, Pion J, Ancian P, Rogue A, Bansard C, Silvano J, Papineau D, Ben Abdeljelil N, Maruggi G, Song H, Spickler C, Blouin K, Dubois G, Rodriguez LA, Baumeister J, Steff AM, Destexhe E. Repeated-Dose Toxicity, Biodistribution, and Shedding Assessments With a ChAd155 Respiratory Syncytial Virus Vaccine Candidate Evaluated in Rabbits and Rats. Int J Toxicol 2022;:10915818221101788. [PMID: 35653115 DOI: 10.1177/10915818221101788] [Reference Citation Analysis]
2 Alagheband Bahrami A, Azargoonjahromi A, Sadraei S, Aarabi A, Payandeh Z, Rajabibazl M. An overview of current drugs and prophylactic vaccines for coronavirus disease 2019 (COVID-19). Cell Mol Biol Lett 2022;27:38. [PMID: 35562685 DOI: 10.1186/s11658-022-00339-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Kandimalla R, Chakraborty P, Vallamkondu J, Chaudhary A, Samanta S, Reddy PH, De Feo V, Dewanjee S. Counting on COVID-19 Vaccine: Insights into the Current Strategies, Progress and Future Challenges. Biomedicines 2021;9:1740. [PMID: 34829969 DOI: 10.3390/biomedicines9111740] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
4 Heinz FX, Stiasny K. Distinguishing features of current COVID-19 vaccines: knowns and unknowns of antigen presentation and modes of action. NPJ Vaccines 2021;6:104. [PMID: 34400651 DOI: 10.1038/s41541-021-00369-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 55] [Article Influence: 5.0] [Reference Citation Analysis]
5 Kamen AA. Vectored-Vaccine Platforms Enabled Rapid Development of Safe and Effective Vaccines in Response to COVID-19 Pandemic Situation. Vaccines (Basel) 2021;9:722. [PMID: 34358139 DOI: 10.3390/vaccines9070722] [Reference Citation Analysis]